Table 1 Age and geographic regions of patients with metastatic colon cancer in the primary analysis (N = 1041)
From: Unsupported off-label chemotherapy in metastatic colon cancer
| Â | N (%) | Â | |
|---|---|---|---|
| Â | All subjects 1041 | Individuals receiving any of the three unsupported off-label therapies 139 (13%) | p -value |
Age | |||
<50 | 277 (27) | 44 (32) | 0.014 |
50-59 | 358 (34) | 52 (37) | |
60-69 | 242 (23) | 34 (24) | |
>70 | 117 (11) | 9 (6) | |
Unknown | 47 (5) | 0 | |
Region | |||
Midwest | 269 (26) | 33 (24) | 0.374 |
Northeast | 107 (10) | 17 (12) | |
Southeast | 370 (36) | 41 (29) | |
Southwest | 126 (12) | 21 (15) | |
West | 96 (9) | 17 (12) | |
Unknown | 72 (7) | 10 (7) | |